DETERMINATION OF THE MINIMAL LEVEL OF NEUTRALIZING ANTIBODIES ELICITED FOLLOWING VACCINATION ABLE TO PROTECT RABBITS AGAINST VIRULENT COWPOX VIRUS

Muratbay Mambetaliyev¹Alina Alieva¹Yergali Abduraimov²Aralbek Rsaliyev²Kuandyk Zhugunissov^1*

• ¹Scientific Research Institute for Biological Safety Problems, Gvardeiskiy, Kazakhstan
• ²National Holding QazBioPharm, Astana, Kazakhstan, Astana, Kazakhstan

Serological assessment of antibody levels is a crucial measure of immunity in vaccinated animals. Establishing the level of antibodies considered protective is essential for vaccine standardization and evaluation of efficacy. The virus neutralization test (VNT), recognized as the gold standard for detecting virus-specific antibodies able to neutralize virus.This study evaluated the effect of viral dose on the detection of humoral immune responses in rabbits vaccinated with a cowpox virus-based vaccine. Blood serum samples were collected on days 14, 21, and 28 post-vaccination. VNT was conducted using viral doses of 100, 50, 25, and 10 TCID₅₀. Additionally, the infectious dose 50 (ID₅₀) of the challenge virus was determined based on the induction of skin necrosis in 50% of infected animals. This dose (316 ID₅₀ per 0.1 mL) was then used to challenge vaccinated rabbits in order to determine the protective antibody titer threshold.Lower viral doses (25 and 10 TCID₅₀) demonstrated higher sensitivity, with neutralizing antibody titers detected at 1:16 and above, significantly exceeding those obtained using 50 and 100 TCID₅₀. Based on these findings, 25 TCID₅₀ was selected as the optimal dose for future VNT. Following cowpox virus challenge, rabbits with neutralizing titers ≥1:16 were protected from skin necrosis, while nonimmunized animals developed characteristic lesions.These results suggest that a low-dose (25 TCID₅₀) VNT improves the sensitivity and that a titer of 1:16 can be considered a protective threshold. This approach provides a reliable laboratory model for assessing the immunogenicity and efficacy of cowpox virus vaccines. The results obtained in this study allow for an objective assessment of the immunity elicited from a cowpox vaccine using a laboratory model.